首页 | 本学科首页   官方微博 | 高级检索  
     


The munich fission neutron therapy facility MEDAPP at the research reactor FRM II
Authors:Franz M. Wagner  Peter Kneschaurek  Anton Kastenmüller  Birgit Loeper-Kabasakal  Severin Kampfer  Harald Breitkreutz  Wolfgang Waschkowski  Michael Molls  Winfried Petry
Affiliation:1. Forschungsneutronenquell Heinz Maier-Leibnitz (FRM II), Technische Universit?t München, Garching, Germany
3. Forschungsneutronenquelle Heinz Meier-Leibnitz (FRM II), Technische Universit?t München, Lichtenbergstr. 1, 85747, Garching, Germany
2. Klinik und Poliklinik für Strahlentherapie und radiologische Onkologie, Klinikum rechts der Isar, Technische Universit?t München, Munich, Germany
Abstract:

Purpose

At the new research reactor FRM II of the Technical University of Munich (TUM), the facility for Medical Applications (MEDAPP) was installed where fast neutrons are available as a beam for medical use.

Material and Methods

Thermal neutrons induce fission in a pair of uranium converter plates and generate fast neutrons which are guided to the patient by a beam tube. The maximum opening of the multi leaf collimator (MLC) is 30 × 20 cm2 W × H. The beam is characterized by neutron-photon mixed beam phantom dosimetry. Specific safety measures are outlined.

Results

The neutron and gamma dose rates are 0.52 Gy/min and 0.20 Gy/min, respectively, in 2 cm depth of a water phantom. The half maximum depth of the neutron dose rate in water is 5.4 cm (mean neutron energy 1.9 ± 0.1 MeV). Conformity with the European Medical Devices Directive (MDD) 93/42/EEG, was proven so that MEDAPP has a CE mark and since February 2007 also the license for clinical operation.

Conclusion

The clinical neutron irradiations of malignant tumors, which were performed at the former research reactor FRM until 2000, can be continued at FRM II under improved conditions. First patients were irradiated in June 2007.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号